Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL CURRENT ASSETS
Total Current Assets HALO - Halozyme Therapeutics, Inc.
1.09 B
LAST VALUE
21.19%
2 YEAR CAGR
14.84%
5 YEAR CAGR
21.00%
10 YEAR CAGR